<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>MicroRNAs (miRNAs) are small non-coding <z:chebi fb="40" ids="33697">RNA</z:chebi> molecules, which act as post-transcriptional regulators of gene expression and have been implicated in initiation, progression and treatment outcome of diverse <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Single nucleotide polymorphisms (SNPs), as the most common type of genetic variation, also exist in miRNA genes and can lead to alteration in miRNA expression resulting in diverse functional consequences </plain></SENT>
<SENT sid="2" pm="."><plain>Emerging studies have evaluated the association of miRNA SNPs with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk, but the results remain inconclusive </plain></SENT>
<SENT sid="3" pm="."><plain>To assess the relationship between miRNA SNPs and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk, we performed a meta-analysis of 18 studies involving 20660 subjects for miR-146a rs2910164 polymorphism and 21 studies involving 26,018 subjects for miR-196a2 rs11614913 polymorphism </plain></SENT>
<SENT sid="4" pm="."><plain>As for rs2910164, no significant association of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk was found in the overall analysis </plain></SENT>
<SENT sid="5" pm="."><plain>In subgroup analysis by <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> type, ethnicity, source of controls and sample size, significant association of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk was mainly found in <z:hpo ids='HP_0002895'>papillary thyroid carcinoma</z:hpo>, primary <z:hpo ids='HP_0002896'>liver cancer</z:hpo>, <z:e sem="disease" ids="C0302592" disease_type="Neoplastic Process" abbrv="">cervical cancer</z:e>, Caucasian population and small sample size studies </plain></SENT>
<SENT sid="6" pm="."><plain>For rs11614913, significant results were found in <z:hpo ids='HP_0000001'>all</z:hpo> the tested genetic models and T allele or its carriers were associated with decreased <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk in overall analysis (T vs. C: OR = 0.888, 95% CI 0.84-0.938; TT+TC vs. CC: OR = 0.897, 95% CI 0.828-0.971) </plain></SENT>
<SENT sid="7" pm="."><plain>In stratified analysis by <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> type and ethnicity, significant association of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk was observed in <z:hpo ids='HP_0003002'>breast cancer</z:hpo>, <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e>, <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and Asian population, but not in Caucasian population </plain></SENT>
<SENT sid="8" pm="."><plain>During further stratified analysis by source of controls and sample size, results similar to those of overall analysis were found in <z:hpo ids='HP_0000001'>all</z:hpo> of the subgroups </plain></SENT>
<SENT sid="9" pm="."><plain>Taken together, our results indicated that miR-196a2 rs11614913 T variant probably contribute to decreased susceptibility to <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>However, limited evidence was found for association of miR-146a rs2910164 with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk, and further well-designed studies with large sample size will be necessary to validate the effect of miR-146a rs2910164 on <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> susceptibility </plain></SENT>
</text></document>